If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,045.00    31.00 (1.03%)
Bid:
3,033.00
Ask:
3,036.00
Spread: 3.00 (0.099%)
Market Cap: £4.24b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

20 May 2010 16:37

RNS Number : 3006M
Croda International PLC
20 May 2010
Β 

ο»Ώ

Annex DTR3

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

All relevant boxes should be completed in block capital letters.

Β 

1.

Name of the issuer

Β 

CRODA INTERNATIONAL PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

BOTH (i) AND (ii)

3.

Name of person discharging managerial

responsibilities/director

Β 

MICHAEL SEAN CHRISTIE

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

RELATES TO DIRECTOR

Β 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non beneficial

interest

Β 

MICHAEL SEAN CHRISTIE

Β 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES OF 10P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

MICHAEL SEAN CHRISTIE

Β 

8.

State the nature of the transaction

Β 

PURCHASE

9.

Number of shares, debentures or financial

instruments relating to shares acquired

Β 

10,000

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

LESS THAN 0.1%

Β 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

Β 

Β 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

Β 

13.

Price per share or value of transaction

Β 

Β£9.04 PER SHARE

Β 

14.

Date and place of transaction

Β 

20 MAY 2010

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

110,154 - LESS THAN 0.1%

Β 

16.

Date issuer informed of transaction

Β 

20 MAY 2010

Β 

Β 

Β 

Β 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

Β 

17.

Date of grant

Β 

Β 

18.

Period during which or date on which exercisable

Β 

Β 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

Β 

Β 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

Β 

Β 

22.

Total number of shares or debentures over which options held following notification

Β 

23.

Any additional information

Β 

NUMBER OF ORDINARY SHARES IN ISSUE, EXCLUDING SHARES HELD IN TREASURY: 137,312,439

Β 

24.

Name of contact and telephone number for queries

Β 

MISS A L SCOTT - 01405 860551

Β 

Name of authorised official of issuer responsible for making notification

Β 

Date of notification 20 MAY 2010

Β 

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

END

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSEBLFLBEFXBBD
Date   Source Headline
13th Mar 202011:58 amRNSDirector/PDMR Shareholding
13th Mar 202011:57 amRNSDirector/PDMR Shareholding
13th Mar 202011:57 amRNSDirector/PDMR Shareholding
13th Mar 202011:56 amRNSDirector/PDMR Shareholding
11th Mar 20202:13 pmRNSDirector/PDMR Shareholding
10th Mar 20204:11 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSResults for the year ended 31 December 2019
12th Feb 20203:47 pmRNSHolding(s) in Company
11th Feb 20203:14 pmRNSDirector/PDMR Shareholding
31st Jan 20204:22 pmRNSHolding(s) in Company
30th Jan 20202:36 pmRNSHolding(s) in Company
14th Jan 20203:42 pmRNSHolding(s) in Company
13th Jan 20204:12 pmRNSDirector/PDMR Shareholding
30th Dec 201911:45 amRNSDirector/PDMR Shareholding
20th Dec 20194:00 pmRNSHolding(s) in Company
17th Dec 20194:52 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSDirectorate Change
12th Dec 201910:40 amRNSDirector/PDMR Shareholding
9th Dec 20193:21 pmRNSHolding(s) in Company
4th Dec 20195:11 pmRNSHolding(s) in Company
27th Nov 20195:13 pmRNSHolding(s) in Company
25th Nov 20193:47 pmRNSHolding(s) in Company
22nd Nov 201910:17 amRNSDirector/PDMR Shareholding
12th Nov 20195:41 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
7th Nov 20196:04 pmRNSHolding(s) in Company
7th Nov 201910:04 amRNSHolding(s) in Company
1st Nov 20194:45 pmRNSDirector/PDMR Shareholding
15th Oct 20194:54 pmRNSTransaction in Own Shares
11th Oct 20195:40 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSCroda investor seminar focusing on Life Sciences
3rd Oct 20194:20 pmRNSDirector/PDMR Shareholding
13th Sep 20192:27 pmRNSDirector/PDMR Shareholding
11th Sep 20193:00 pmRNSDirector/PDMR Shareholding
11th Sep 20192:28 pmRNSHolding(s) in Company
13th Aug 20194:12 pmRNSDirector/PDMR Shareholding
25th Jul 20193:35 pmRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSResults for the six months ended 30 June 2019
11th Jul 20193:11 pmRNSDirector/PDMR Shareholding
14th Jun 20193:01 pmRNSDirector/PDMR Shareholding
4th Jun 20193:24 pmRNSDirector/PDMR Shareholding
13th May 20193:20 pmRNSDirector/PDMR Shareholding
3rd May 20192:59 pmRNSDirector/PDMR Shareholding
1st May 20194:32 pmRNSDirector/PDMR Shareholding
29th Apr 20198:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.